Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
Clinical trial NCT04356781 · COMPLETED
Trial details
- NCT number
- NCT04356781
- Sponsor
- Walton Centre NHS Foundation Trust
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-28
- Primary completion
- 2024-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.